- Home
- SGMO vs CHCI Comparison
SGMO vs CHCI Comparison
Compare SGMO & CHCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- CHCI
- Stock Information
- Founded
- SGMO 1995
- CHCI 1985
- Country
- SGMO United States
- CHCI United States
- Employees
- SGMO N/A
- CHCI N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- CHCI Building operators
- Sector
- SGMO Health Care
- CHCI Real Estate
- Exchange
- SGMO Nasdaq
- CHCI Nasdaq
- Market Cap
- SGMO 122.8M
- CHCI 100.9M
- IPO Year
- SGMO 2000
- CHCI 2004
- Fundamental
- Price
- SGMO $0.59
- CHCI $12.26
- Analyst Decision
- SGMO Buy
- CHCI
- Analyst Count
- SGMO 6
- CHCI 0
- Target Price
- SGMO $4.50
- CHCI N/A
- AVG Volume (30 Days)
- SGMO 5.2M
- CHCI 25.2K
- Earning Date
- SGMO 08-05-2025
- CHCI 08-07-2025
- Dividend Yield
- SGMO N/A
- CHCI N/A
- EPS Growth
- SGMO N/A
- CHCI 85.70
- EPS
- SGMO N/A
- CHCI 1.46
- Revenue
- SGMO $63,756,000.00
- CHCI $53,295,000.00
- Revenue This Year
- SGMO $1.29
- CHCI N/A
- Revenue Next Year
- SGMO $1.60
- CHCI N/A
- P/E Ratio
- SGMO N/A
- CHCI $8.37
- Revenue Growth
- SGMO 239.92
- CHCI 18.21
- 52 Week Low
- SGMO $0.41
- CHCI $6.15
- 52 Week High
- SGMO $3.18
- CHCI $14.48
- Technical
- Relative Strength Index (RSI)
- SGMO 60.91
- CHCI 62.83
- Support Level
- SGMO $0.50
- CHCI $11.85
- Resistance Level
- SGMO $0.65
- CHCI $12.32
- Average True Range (ATR)
- SGMO 0.04
- CHCI 0.56
- MACD
- SGMO 0.01
- CHCI -0.00
- Stochastic Oscillator
- SGMO 64.22
- CHCI 66.89
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About CHCI Comstock Holding Companies Inc.
Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.